Asterima Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 0.62 M
as on 22-12-2024
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 22-12-2024
- Revenue %
(FY 2019)
- Net Worth -431.75%
(FY 2019)
- Total Assets 121.75%
(FY 2019)
About Asterima Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.62 M.
The company currently has active open charges totaling ₹3.00 M.
Diju Prabhakaran, Sandeep Prabhakaran, Soumya Tomy, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2016PTC280401
- Company No.
280401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Asterima Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saneesh Methanath  | Managing Director | 30-Apr-2016 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Prabhakaran | Director | 02-Nov-2020 | Current |
| Diju Prabhakaran | Director | 02-Nov-2020 | Current |
| Soumya Tomy | Director | 13-Dec-2022 | Current |
| Girish | Director | 01-Oct-2021 | Current |
| Arun | Director | 01-Oct-2021 | Current |
| Mandeep Warrier | Director | 10-Jul-2021 | Current |
Financial Performance of Asterima Pharmaceuticals.
Asterima Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 431.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Asterima Pharmaceuticals?
In 2019, Asterima Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Grand Pharma Distributors Private LimitedActive 3 years 5 monthsSandeep Prabhakaran and Saneesh Methanath are mutual person
Asterima Nutricare Private LimitedActive 4 years 8 daysDiju Prabhakaran, Sandeep Prabhakaran and 4 more are mutual person
- Boho Media Limited Liability PartnershipActive 3 years 7 months
Sandeep Prabhakaran is a mutual person
- Solve Vitality Healthcare Solutions Private LimitedActive 10 months 14 days
Sandeep Prabhakaran is a mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Dhanlaxmi Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2022 | Dhanlaxmi Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Asterima Pharmaceuticals?
Unlock and access historical data on people associated with Asterima Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asterima Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asterima Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
